Tumor treating fields as novel combination partner in the multimodal treatment of head and neck cancer

被引:5
作者
Regnery, Sebastian [1 ]
Franke, Henrik [1 ,2 ]
Held, Thomas [1 ,2 ]
Trinh, Thuy [1 ,2 ]
Naveh, Ariel [3 ]
Abraham, Yissachar [3 ]
Hoerner-Rieber, Juliane [1 ,2 ]
Hess, Jochen [4 ,5 ]
Huber, Peter E. [1 ,2 ]
Debus, Juergen [1 ,2 ]
Perez, Ramon Lopez [2 ]
Adeberg, Sebastian [1 ,2 ,6 ]
机构
[1] Heidelberg Univ Hosp, Dept Radiat Oncol, Heidelberg, Germany
[2] German Canc Res Ctr, Clin Cooperat Unit Mol & Radiat Oncol, Heidelberg, Germany
[3] Novocure Ltd, Haifa, Israel
[4] Heidelberg Univ Hosp, Dept Otorhinolaryngol, Sect Expt & Translat Head & neck Oncol, Heidelberg, Germany
[5] German Canc Res Ctr, Res Grp Mol Mech Head & Neck Tumors, Heidelberg, Germany
[6] Heidelberg Univ Hosp, Dept Radiat Oncol, Im Neuenheimer Feld 400, D-69120 Heidelberg, Germany
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2023年 / 45卷 / 04期
关键词
chemoradiotherapy; head and neck cancer; radiotherapy; squamous cell carcinoma of head and neck; tumor treating fields; CELLS IN-VITRO; CHEMOTHERAPY; TTFIELDS; TRIALS; PROLIFERATION; DISRUPTION; VIVO;
D O I
10.1002/hed.27298
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
BackgroundWe aimed to demonstrate the effects of tumor treating fields (TTFields) in head and neck squamous cell carcinoma (HNSCC) cells when combined with radiotherapy (RT) and chemotherapy. MethodsTwo human HNSCC cell lines (Cal27, FaDu) received five different treatments: TTFields, RT +/- TTFields and RT + simultaneous cisplatin +/- TTFields. Effects were quantified using clonogenic assays and flow cytometric analyses of DAPI, caspase-3 activation and gamma H2AX foci. ResultsTreatment with RT + TTFields decreased the clonogenic survival as strong as treatment with RT + simultaneous cisplatin. The triple combination of RT + simultaneous cisplatin + TTFields even further decreased the clonogenic survival. Accordingly, combination of TTFields with RT or RT + simultaneous cisplatin increased cellular apoptosis and DNA double-strand breaks. ConclusionTTFields therapy seems a promising combination partner in the multimodal treatment of locally advanced HNSCC. It could be used to intensify chemoradiotherapy or as alternative to chemotherapy.
引用
收藏
页码:838 / 848
页数:11
相关论文
共 50 条
  • [31] Tumor Treating Fields (TTFields) Therapy Concomitant with Taxanes for Cancer Treatment
    Vergote, Ignace
    Macarulla, Teresa
    Hirsch, Fred R.
    Hagemann, Carsten
    Miller, David Scott
    CANCERS, 2023, 15 (03)
  • [32] Tumor treating fields: narrative review of a promising treatment modality for cancer
    Kutuk, Tugce
    Atak, Ece
    La Rosa, Alonso
    Kotecha, Rupesh
    Mehta, Minesh P.
    Chuong, Michael D.
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (06)
  • [33] Tumor treating fields in combination with gemcitabine or gemcitabine plus nab-paclitaxel in pancreatic cancer: Results of the PANOVA phase 2 study
    Rivera, Fernando
    Benavides, Manuel
    Gallego, Javier
    Guillen-Ponce, Carmen
    Lopez-Martin, Jose
    Kung, Marc
    PANCREATOLOGY, 2019, 19 (01) : 64 - 72
  • [34] Multimodal treatment strategy for Langerhans cell histiocytosis at head and neck manifestations
    Becker, G
    Bücheler, M
    Paulsen, F
    Denzlinger, C
    Belka, C
    Plinkert, PK
    HNO, 2003, 51 (01) : 55 - 60
  • [35] Treatment tolerability and outcomes in elderly patients with head and neck cancer
    Dickstein, Daniel R.
    Egerman, Marc
    Monrose, Erica
    Varma, Achintya
    Ozbek, Umut
    Sharma, Sonam
    Liu, Jerry T.
    Gupta, Vishal
    Posner, Marshall R.
    Misiukiewicz, Krzysztof
    Miles, Brett A.
    Genden, Eric
    Bakst, Richard L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2021, 43 (03): : 858 - 873
  • [36] Review on prevention and treatment of oral mucositis in head and neck cancer
    Bartolome-Alonso, Alba
    Luis Pardal-Refoyo, Jose
    REVISTA ORL, 2019, 10 (04) : 269 - 277
  • [37] Tumor-treating fields in combination with sorafenib restrain the proliferation of liver cancer in vitro
    Jang, Yoonjung
    Lee, Won Seok
    Sai, Sei
    Kim, Jeong Yub
    Kim, Jong-Ki
    Kim, Eun Ho
    ONCOLOGY LETTERS, 2022, 24 (04)
  • [38] The Association of Education, Employment and Living with a Partner with the Treatment among Patients with Head and Neck Cancer
    Stefkova, Gabriela
    Veselska, Zuzana Dankulincova
    Vargova, Viola
    Palo, Marek
    AIMS PUBLIC HEALTH, 2015, 2 (01): : 1 - 9
  • [39] Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Tumor control and late toxicity
    Nevens, Daan
    Duprez, Frederic
    Bonte, Katrien
    Deron, Philippe
    Huvenne, Wouter
    Laenen, Annouschka
    De Neve, Wilfried
    Nuyts, Sandra
    RADIOTHERAPY AND ONCOLOGY, 2017, 124 (02) : 220 - 224
  • [40] Tumor biology of head and neck cancer
    Tinhofer-Keilholz, I.
    ONKOLOGE, 2014, 20 (02): : 130 - 138